Santhera Pharmaceuticals Holding AG / Estimates

    Fiscal Year Revenue Net income Net margin Free cash flow FCF margin
    (estimated) N/A N/A N/A N/A N/A
    (estimated) €122.98M +18.9% €5.67M +126.5% 4.6% +0.022 pp €3.21M -31.8% 2.6% -0.019 pp
    (estimated) €103.45M +36.5% €2.50M -107.2% 2.4% +0.48 pp €4.71M -109.2% 4.6% +0.72 pp
    (estimated) €75.78M +81.0% -€34.88M -22.4% -46.0% +0.61 pp -€51.27M +35.4% -67.7% +0.23 pp
    €41.87M -62.2% -€44.93M -176.6% -107.3% -1.6 pp -€37.86M -149.8% -90.4% -1.6 pp
    €110.69M +1,283.8% €58.63M -177.1% 53.0% +10 pp €76.01M -374.3% 68.7% +4.2 pp
    €8.00M -568.5% -€76.07M +28.0% -951.1% -44 pp -€27.71M -30.7% -346.4% -27 pp
    -€1.71M -110.6% -€59.43M -17.9% 3,481.3% +39 pp -€39.97M -14.1% 2,341.3% +26 pp
    €16.06M -80.1% -€72.42M +256.6% -450.8% -4.3 pp -€46.53M -1,639.5% -289.7% -2.9 pp
    €80.68M +138.1% -€20.31M -65.0% -25.2% +1.5 pp €3.02M -117.4% 3.7% +0.55 pp
    €33.88M +38.0% -€58.00M +5.2% -171.2% +0.53 pp -€17.36M -57.6% -51.2% +1.2 pp
    €24.56M +20.5% -€55.16M +45.5% -224.6% -0.39 pp -€40.92M +42.9% -166.7% -0.26 pp
    €20.37M +340.5% -€37.91M -695.3% -186.1% -3.2 pp -€28.64M +22.3% -140.6% +3.7 pp
    €4.62M +66.8% €6.37M -179.0% 137.7% +4.3 pp -€23.41M +273.5% -506.2% -2.8 pp
    €2.77M +96.4% -€8.06M +30.9% -290.8% +1.5 pp -€6.27M -16.0% -226.0% +3.0 pp
    €1.41M -62.7% -€6.16M -81.7% -436.3% +4.5 pp -€7.46M -36.7% -528.6% -2.2 pp
    €3.79M +8.4% -€33.66M +13.0% -888.9% -0.36 pp -€11.78M -44.4% -311.1% +3.0 pp
    €3.49M -84.2% -€29.80M +147.3% -852.6% -8.0 pp -€21.20M +202.4% -606.6% -5.7 pp
    €22.06M +1,154.4% -€12.05M -143.4% -54.6% -16 pp -€7.01M -66.9% -31.8% +12 pp
    €1.76M +3,322.9% €27.75M -158.1% 1,577.8% +950 pp -€21.15M -55.9% -1,202.9% +920 pp
    €51.38K -99.5% -€47.80M +60.2% -93,033.3% -930 pp -€47.95M +105.4% -93,333.3% -930 pp
    €9.87M +1,081.3% -€29.83M -1.4% -302.1% +33 pp -€23.35M -7.7% -236.5% +28 pp
    €835.92K -€30.25M -3,618.2% -€25.31M -3,027.3%

    Notifications